Varizig approved to reduce chickenpox symptoms

Varizig approved to reduce chickenpox symptoms
Varizig (varicella zoster immune globulin) has been approved by the U.S. Food and Drug Administration to minimize chickenpox symptoms when administered within four days of exposure to the virus that causes the disease.

(HealthDay)—Varizig (varicella zoster immune globulin) has been approved by the U.S. Food and Drug Administration to minimize chickenpox symptoms when administered within four days of exposure to the virus that causes the disease.

Varizig was approved for high-risk people, including those with compromised immune systems, newborns, pregnant women, , children less than a year old, and people with no immunity to the virus, the FDA said Friday in a news release.

Varizig is produced from the of healthy donors with high levels of antibodies to the chicken-pox-causing virus, the FDA said. The donated plasma comes from collection facilities licensed by the FDA.

The drug is meant to be administered in one or more doses, depending on the recipient's weight, within 96 hours of exposure. The most common side effects noted in clinical testing were injection-site pain and headache.

Varizig is produced by Cangene Corp., based in Winnipeg, Canada.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

New drug approved for lack of certain white blood cells

Aug 30, 2012

(HealthDay)—The U.S. Food and Drug Administration has approved the drug tbo-filgrastim to treat certain cancer patients undergoing chemotherapy who have a condition called severe neutropenia, the FDA said in a news release.

Generic boniva approved for osteoporosis

Mar 19, 2012

(HealthDay) -- The first generic versions of the once-monthly osteoporosis drug Boniva (ibandronate) have been approved by the U.S. Food and Drug Administration.

Recommended for you

Drug research and development more efficient than expected

Feb 27, 2015

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.